SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Loxo Oncology, Inc. (LOXO)

Add LOXO Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/6/2017 5:45:12 AM - Followers: 0 - Board type: Free - Posts Today: 0

Loxo Oncology, Inc. One Landmark Square Suite 1122 Stamford, CT 06901 United States Phone: 203-653-3880 Website: Loxo Oncology, Inc. engages in the discovery, development, and commercialization of cancer therapies in the United States. Its lead product candidate includes LOXO-101, an oral and selective inhibitor of tropomyosin receptor kinase (TRK), which is in a Phase I dose escalation trial for the treatment of patients with tumor types, such as lung, head and neck, melanoma, colorectal, sarcoma, and breast cancer. The company’s preclinical programs include RET inhibitor that optimizes potency for RET fusion proteins, mutations, and clinically-identified resistance mutations; FGFR inhibitor that optimizes on potency against receptors comprising four isoforms with tyrosine kinase domains; and FLT3 inhibitor that optimizes on potency for the FLT3 internal tandem duplication mutations. It has a drug discovery collaboration agreement with Array BioPharma, Inc. to obtain various rights to TRK inhibitor program and oncology targets. The company was founded in 2013 and is headquartered in Stamford, Connecticut.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
LOXO News: Loxo Oncology Announces Details of Two Larotrectinib Clinical Data Oral Presentations at the 2017 American Society of Clinica... 05/17/2017 05:00:00 PM
LOXO News: Loxo Oncology Announces FDA Orphan Drug Designation Granted to Larotrectinib for the Treatment of Solid Tumors with NTRK-Fusi... 05/12/2017 06:45:00 AM
LOXO News: Loxo Oncology Announces Enrollment of First Patient in Phase 1 Clinical Trial for Highly Selective RET Inhibitor, LOXO-292 05/10/2017 06:45:00 AM
LOXO News: Quarterly Report (10-q) 05/09/2017 04:05:17 PM
LOXO News: Current Report Filing (8-k) 05/09/2017 06:47:09 AM
#5   Loxo Oncology (LOXO +5.28%) fell over 3% in jones99 01/06/17 05:45:12 AM
#4   $LOXO *DJ Loxo Oncology Announces EMA Orphan Drug jones99 01/15/16 06:53:46 AM
#3   Eyeing this oncology stock as my top biotech edge 01/02/16 03:50:24 PM
#2   " agraff04 06/15/15 03:13:43 PM
#1   $LOXO recent news/filings stocktrademan 06/13/15 09:58:05 PM